Kia has become the first automaker to publicly test an electric vehicle (EV) battery passport system at the cell level. The new technology aims to make EV ownership more affordable. The pilot program, ...

Durability and battery life were the main concerns when Apple unveiled the iPhone Air, but we quickly got our first answers. The glass may break after accidental drops, but the iPhone Air will not ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources, including ...

The Pixel 10 Pro Fold battery exploded during JerryRigEverything’s durability test. It snapped along the same weak antenna line as past Folds, and the IP rating was called into question. The YouTuber ...

With more than a decade of experience, Nelson covers Apple and Google and writes about iPhone and Android features, privacy and security settings, and more. Jason Chun is a CNET writer covering a ...

Posts from this topic will be added to your daily email digest and your homepage feed. After a big bend, the battery appears to overheat — but iFixit isn’t worried. After a big bend, the battery ...

The iPhone 17 Pro Max introduces a significant enhancement in battery performance, marking a clear improvement over its predecessor, the iPhone 16 Pro Max. If you prioritize extended usage time and ...

We've tested hundreds of laptops to find the ones that last the longest between charges. These battery-life champs will easily take you through a day of work or school, plus an evening's entertainment ...

Google’s brand new Pixel 10 Pro Fold, which went on sale last week, has been subjected to an extreme durability test. The test results suggest that the foldable may not be as durable as Google claims.

Battery life has always been a key battleground for smartphones, and Oppo’s upcoming Find X9 Pro seems ready to take that fight seriously. Ahead of its official debut on October 16, early tests ...

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects due to a stubborn refusal to pay for innovative new medicines, according to the pharma ...